David Steinberg
Stock Analyst at Jefferies
(2.83)
# 1,742
Out of 4,908 analysts
35
Total ratings
59.26%
Success rate
20.07%
Average return
Main Sectors:
Top Industries:
Stocks Rated by David Steinberg
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BHC Bausch Health Companies | Downgrades: Hold | $12 → $8 | $6.51 | +22.89% | 7 | Feb 6, 2025 | |
| PRGO Perrigo Company | Upgrades: Buy | $45 → $63 | $27.55 | +128.68% | 8 | Sep 30, 2021 | |
| SUPN Supernus Pharmaceuticals | Upgrades: Buy | $25 → $40 | $32.69 | +22.38% | 11 | Apr 13, 2021 | |
| JAZZ Jazz Pharmaceuticals | Maintains: Buy | $151 → $188 | $116.34 | +61.60% | 5 | Oct 9, 2020 | |
| OCUL Ocular Therapeutix | Initiates: Buy | $8 | $11.55 | -30.74% | 1 | Mar 17, 2020 | |
| SCPH scPharmaceuticals | Maintains: Buy | $26 → $12 | $5.38 | +123.05% | 2 | Jun 14, 2018 | |
| SVRA Savara | Initiates: Buy | $20 | $2.41 | +729.88% | 1 | Sep 22, 2017 |
Bausch Health Companies
Feb 6, 2025
Downgrades: Hold
Price Target: $12 → $8
Current: $6.51
Upside: +22.89%
Perrigo Company
Sep 30, 2021
Upgrades: Buy
Price Target: $45 → $63
Current: $27.55
Upside: +128.68%
Supernus Pharmaceuticals
Apr 13, 2021
Upgrades: Buy
Price Target: $25 → $40
Current: $32.69
Upside: +22.38%
Jazz Pharmaceuticals
Oct 9, 2020
Maintains: Buy
Price Target: $151 → $188
Current: $116.34
Upside: +61.60%
Ocular Therapeutix
Mar 17, 2020
Initiates: Buy
Price Target: $8
Current: $11.55
Upside: -30.74%
scPharmaceuticals
Jun 14, 2018
Maintains: Buy
Price Target: $26 → $12
Current: $5.38
Upside: +123.05%
Savara
Sep 22, 2017
Initiates: Buy
Price Target: $20
Current: $2.41
Upside: +729.88%